Company · CIK 1443411
Novartis Capital CORP
| CIK | 1443411 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | NY |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | none on EDGAR |
Offerings
0 registrationsNo offering chain starts here after 2002-11-04: the company's filings belong to registrations filed earlier, or to drafts and notices only.
Filings
19| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2026-03-17 | 424B5Shelf takedown | 333-282133-01 | 0001104659-26-029551 |
| 2026-03-16 | 424B5Shelf takedown | 333-282133-01 | 0001104659-26-028048 |
| 2025-11-04 | 424B5Shelf takedown | 333-282133-01 | 0001104659-25-106338 |
| 2025-11-03 | 424B5Shelf takedown | 333-282133-01 | 0001104659-25-105278 |
| 2024-09-17 | 424B5Shelf takedown | 333-282133-01 | 0001104659-24-100712 |
| 2024-09-16 | 424B5Shelf takedown | 333-282133-01 | 0001104659-24-100040 |
| 2020-02-12 | 424B5Shelf takedown | 333-236162-01 | 0001047469-20-000837 |
| 2020-02-11 | 424B5Shelf takedown | 333-236162-01 | 0001047469-20-000795 |
| 2017-02-15 | 424B5Shelf takedown | 333-207004-02 | 0001047469-17-000686 |
| 2017-02-14 | 424B5Shelf takedown | 333-207004-02 | 0001047469-17-000659 |
| 2015-11-18 | 424B5Shelf takedown | 333-207004-02 | 0001047469-15-008772 |
| 2015-11-17 | 424B5Shelf takedown | 333-207004-02 | 0001047469-15-008723 |
| 2014-02-19 | 424B5Shelf takedown | 333-183955-02 | 0001047469-14-001027 |
| 2014-02-18 | 424B5Shelf takedown | 333-183955-02 | 0001047469-14-000961 |
| 2012-09-19 | 424B5Shelf takedown | 333-183955-02 | 0001047469-12-008953 |
| 2012-09-18 | 424B5Shelf takedown | 333-183955-02 | 0001047469-12-008899 |
| 2010-03-10 | 424B5Shelf takedown | 333-153696-03 | 0001047469-10-001989 |
| 2010-03-09 | 424B5Shelf takedown | 333-153696-03 | 0001047469-10-001907 |
| 2009-02-03 | 424B5Shelf takedown | 333-153696-03 | 0001047469-09-000541 |